4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001348362-20-000005
Options or other derivatives
- Chief Executive Officer disposed of 700,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
BUNKA CHRISTOPHER · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-03-23 | Other disposition : show line 1 in the form stock options | −700,000 | 0 | D |
Loading xslF345X03/primary_doc.xml…